Ryan Garcia, the 24-1 boxing prodigy, recently revealed his intention to return to boxing this December, despite a one-year suspension. His suspension came about after a positive test for the banned substance ostarine in April, which was enforced by the New York State Athletic Commission.

Despite the setback and having his earnings from the fight against Devin Haney surrendered, Garcia is adamant about not having knowingly taken the banned substance and is eager to continue his boxing journey.

In a recent interview, an undeterred Garcia announced his comeback, expressing enthusiasm about an upcoming big fight in December that his fans should anticipate. This declaration raises eyebrows within the boxing community, as many question how he will bypass the restrictions of his suspension.

Previously in April, Garcia secured a win against Devin Haney, but the bout’s result was negated following the findings of his drug test. Garcia has repeated his innocence, blaming the result on a contaminated supplement.

Currently, under the terms of his ban, Garcia is disabled from competing in New York and probably elsewhere in the United States until April 2025. Nevertheless, he might bypass these constraints by fighting abroad or participating in an event outside the jurisdiction of state boxing commissions. There’s even talk about him potentially entering an MMA ring, a venture he has hinted at before.

While Garcia’s immediate future in boxing hangs in the balance, his resolve to step back into the ring has not waned. As he gears up for whatever challenge comes next, both supporters and critics are keyed in, eager to see how he manages these hurdles.

**Update:**
As the probe into Garcia’s positive test for ostarine progresses, experts continue to discuss how the substance could significantly boost an athlete’s lean muscle mass. Amidst ongoing debates and the shadow of his suspension, Garcia stays focused on his career in sports, leaving many questioning how he will navigate his promising yet currently tumultuous boxing career.